Yes We Can (Use Nirmatrelvir/Ritonavir Even in High Immunological Risk Patients Treated with Immunosuppressive Drugs)! Florian Lemaitre Editorial 23 July 2022 Pages: 1071 - 1073
Clinical Pharmacokinetics of Gentamicin in Various Patient Populations and Consequences for Optimal Dosing for Gram-Negative Infections: An Updated Review Caspar J. HodiamontAnnemieke K. van den BroekReinier M. van Hest Review Article Open access 27 June 2022 Pages: 1075 - 1094
Clinical Pharmacokinetics of Metoprolol: A Systematic Review Ammara ZamirIltaf HussainMuhammad Fawad Rasool Systematic Review 28 June 2022 Pages: 1095 - 1114
Prediction of Drug–Drug Interactions After Esketamine Intranasal Administration Using a Physiologically Based Pharmacokinetic Model Marie-Emilie WilleminPeter ZannikosJan Snoeys Original Research Article 17 May 2022 Pages: 1115 - 1128
Prediction of Maternal and Fetal Doravirine Exposure by Integrating Physiologically Based Pharmacokinetic Modeling and Human Placenta Perfusion Experiments V. E. BukkemsH. van HoveA. Colbers Original Research Article Open access 17 May 2022 Pages: 1129 - 1141
Safety, Pharmacodynamics, and Pharmacokinetics of P2X3 Receptor Antagonist Eliapixant (BAY 1817080) in Healthy Subjects: Double-Blind Randomized Study Christian FriedrichKlaus FranckeAlyn Morice Original Research Article Open access 28 May 2022 Pages: 1143 - 1156
A Hybrid Model Associating Population Pharmacokinetics with Machine Learning: A Case Study with Iohexol Clearance Estimation Alexandre DesterePierre MarquetJean-Baptiste Woillard Original Research Article 31 May 2022 Pages: 1157 - 1165
Ciprofloxacin Pharmacokinetics After Oral and Intravenous Administration in (Morbidly) Obese and Non-obese Individuals: A Prospective Clinical Study Koen P. van RheeCornelis SmitCatherijne A. J. Knibbe Original Research Article Open access 01 June 2022 Pages: 1167 - 1175
Population Pharmacokinetics of Delamanid and its Main Metabolite DM-6705 in Drug-Resistant Tuberculosis Patients Receiving Delamanid Alone or Coadministered with Bedaquiline Lénaïg TanneauMats O. KarlssonElin M. Svensson Original Research Article Open access 07 June 2022 Pages: 1177 - 1185
Phenytoin Metabolic Ratio, a Marker of CYP2C9 Activity, is Superior to the CYP2C9 Genotype as a Predictor of (S)-Warfarin Clearance Chanan ShaulSimcha BlotnickYoseph Caraco Original Research Article 14 June 2022 Pages: 1187 - 1198